Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 72 | Longs Won 31/63 49% | Profit Factor 1.11 |
| Profitability | Shorts Won 5/9 55% | Standard Deviation $6,491.33 |
| Average Win $3,917.04 | Best Trade (Oct 27) $19,606.58 | Sharpe Ratio -59.13 |
| Average Loss -$3,520.92 | Worst Trade (Feb 16) -$24,816.47 | Z-Score -1.31 (81.03%) |
| Commissions $0 | Avg. Trade Length 2m 1w 2d | Expectancy $198.06 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 9.06% | 18.66% | 28.48% | 38.45% | 48.53% | 58.69% | 68.93% | 79.23% | 89.59% |
| Consecutive Losing Trades | 32 | 29 | 26 | 23 | 19 | 16 | 13 | 10 | 6 | 3 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AGIO Agios Pharmaceuticals Inc. | 3,174.78 | $93,386.51 | $114,260.21 | - | $20,873.7 | 22.35% | -2.651% |